SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Revenue

SCI Pharmtech had revenue of 256.44M TWD in the quarter ending September 30, 2025, a decrease of -38.84%. This brings the company's revenue in the last twelve months to 1.39B, down -1.64% year-over-year. In the year 2024, SCI Pharmtech had annual revenue of 1.52B with 26.54% growth.

• Revenue (ttm): 1.39B
• Revenue Growth: -1.64%
• P/S Ratio: 4.17
• Revenue / Employee: 5.82M
• Employees: 239
• Market Cap: 5.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.52B	319.58M	26.54%
Dec 31, 2023	1.20B	304.42M	33.83%
Dec 31, 2022	899.74M	35.52M	4.11%
Dec 31, 2021	864.22M	-1.83B	-67.86%
Dec 31, 2020	2.69B	333.48M	14.16%